|Previous Section||Index||Home Page|
|SHA of treatment||Under 18||18 and over|
A FAE is the first period of in-patient care under one consultant within one healthcare provider. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year.
2. Data quality:
HES are compiled from data sent by over 300 national health service trusts, and primary care trusts (PCTs) in England. Data are also received from a number of independent sector organisations for activity commissioned by the English NHS. The Information Centre for health and social care liaises closely with these organisations to encourage submission of complete and valid data and seeks to minimise inaccuracies and the effect of missing and invalid data via HES processes. While this brings about improvement over time, some shortcomings remain.
3. Ungrossed data:
Figures have not been adjusted for shortfalls in data (ie the data are ungrossed).
4. Low numbers:
Due to reasons of confidentiality, figures between one and five have been suppressed and replaced with *(an asterisk).
Hospital Episode Statistics (HES), The Information Centre for health and social care
|Financial year||Grants (£)|
Bill Etherington: To ask the Secretary of State for Health what specialist training is available for general practitioners to ensure that primary care services respond to the health needs of patients presenting with severe alcohol dependency. 
Dawn Primarolo: It is the responsibility of primary care trusts to ensure that their existing health care staff are well trained and provided with the opportunity to receive continuing professional development.
However, the Government are committed to actively supporting the training of undergraduate doctors, some of whom will go on to become general practitioners, in helping to reduce the harms that are attributable to alcohol misuse.
This will include ensuring that around 60,000 new doctors leaving medical training in England, over a 10 year period, will be able to deliver competent practice in both drug and alcohol misuse, including a clear focus on the recognition and the management of risky and harmful alcohol consumption.
We allocated £650,000 in 2008 for the developmental work medical schools will need to carry out, to embed such an integrated substance misuse curriculum into their own core teaching and training programmes. This funding will enable the first major tranche of medical schools to make the changes needed; with full roll-out across all schools over the following three years.
Dawn Primarolo: The Medicines and Healthcare products Regulatory Agency (MHRA) has received five written inquiries and three telephone inquiries, one of which related directly to one of the written inquiries, concerning sublingual immunotherapy (SLIT) products used for desensitisation to allergies.
These products are unlicensed medicinal products and importation from elsewhere in the European Economic Area requires prior notification to the MHRA by a licensed importer. Notifications are assessed for regulatory compliance and for known issues with safety and quality and the MHRA may object to importation. In 2005 the Committee on Safety of Medicines (CSM, now the Commission on Human Medicines, (CHM) advised the MHRA that they should not object to the importation of unlicensed pollen based SLIT products, provided they were for use in non-asthmatic adults under the supervision of NHS specialists with access to resuscitation equipment. On this basis, the MHRA will object to importation of all non-pollen based SLIT products.
The MHRA has recently become aware that certain unlicensed SLIT products have been imported into the United Kingdom without prior notification to the Agency. The importer has been instructed to cease importation and distribution.
The MHRA is encouraging importers to make appropriate notifications. Some have been received and assessed in line with the CSM advice, with non-objections to import issued for pollen based SLIT products. Non-pollen based SLIT products continue to attract objections to import.
Mr. Bradshaw: It is the responsibility of primary care trusts (PCTs) to plan, develop and improve health services for their local population. This is therefore a matter for West Sussex PCT, which is working to develop its business case in relation to the planned new facility in Littlehampton with the support of the South East Coast strategic health authority.
Phil Hope: The information requested is not held centrally. However, it is the responsibility of primary care trusts to ensure that the services they commission meet the needs of the communities that they serve. This includes the commissioning of services for those people with autism.
Dawn Primarolo: As at 6pm on 17 February 2009, UK Biobank had recruited 258,542 people. It aims to recruit 500,000 people aged 40-69 who agree to be part of this important national resource for health research. It is on target to achieve this by mid-2010.
Jenny Willott: To ask the Secretary of State for Health what (a) correspondence and (b) meetings his Department has with the inquiry team of the independent public inquiry into contaminated blood products (i) prior to and (ii) subsequent to the beginning of the inquiry; on which dates such meetings occurred; and if he will make a statement. 
Officials from the Department attended four meetings with the Inquiry. These took place on 25 April 2007, 19 September 2007, 18 February 2008 and 12 June 2008. No meetings were held prior to the start of the inquiry.
The following table shows the main correspondence between the Department and the Inquiry team. The remaining items consisted of e-mails discussing administrative arrangements relating to meetings and the delivery of documents.
|Next Section||Index||Home Page|